[#item_full_content]On April 23, 2026, the U.S. Department of Justice (DOJ) and Drug Enforcement Administration (DEA) reclassified FDA‑approved marijuana products and state‑licensed medical marijuana from Schedule I to Schedule III. This move is the first major federal action in over 50 years to change marijuana’s classification. The Controlled Substances Act (CSA) of 1970 established a…
Read More